-
公开(公告)号:US20240293444A1
公开(公告)日:2024-09-05
申请号:US18653713
申请日:2024-05-02
Applicant: MedinCell S.A.
Inventor: Christophe ROBERGE , Adolfo LÓPEZ-NORIEGA , Jean-Manuel CROS , Juliette SERINDOUX , Murielle OSTER , Fang LIU , Charlotte MOLINIER , Sylvestre GRIZOT , Tjasa VRLINIC , Feifei NG , Elise GUÉGAIN , Marie-Emérentienne CAGNON
IPC: A61K31/765 , A61K9/00 , A61K31/445 , A61K31/4985 , A61K31/5415 , A61K31/675 , A61K31/7048 , A61K47/34
CPC classification number: A61K31/765 , A61K9/0024 , A61K31/445 , A61K31/4985 , A61K31/5415 , A61K31/675 , A61K31/7048 , A61K47/34
Abstract: The present invention provides a pharmaceutical composition comprising:
a biodegradable multi-branched copolymer comprising at least three polyester arms attached to a central core which comprises a polyether, and wherein the multi-branched copolymer is substantially insoluble in aqueous solution, further comprising at least one pharmaceutically active ingredient.-
公开(公告)号:US20250009647A1
公开(公告)日:2025-01-09
申请号:US18294961
申请日:2022-08-05
Applicant: MedinCell S.A.
Inventor: Juliette SERINDOUX , Adolfo LÓPEZ-NORIEGA
Abstract: The present invention provides a pharmaceutical composition comprising or consisting of at least one polyether-polyester copolymer, wherein the copolymer has the formula: B(A)n wherein B represents a polyether and comprises polyethylene glycol (PEG), each A represents a polyester arm and n is an integer from 1 to 8; at least one nucleophilic compound; at least one organic solvent; and up to 10% (w/w) of at least one acidic compound having a pKa(H2O) of less than 3.
-